Friday, September 04, 2026

What's Working in SCI Research

 

New Mobility Logo
NEW MOBILITY HEALTH & WELLNESS
August 2026 - View in browser
IN PARTNERSHIP WITH KALOGON
— ON A MISSION TO ELIMINATE THE STRESSES OF SITTING —

logo
THIS MONTH: SCI Research Update
We're excited to turn the Health and Wellness newsletter over to its first guest editor, Matthew Rodreick, the executive director at Unite 2 Fight Paralysis (U2FP) and father to a son with SCI. U2FP is a grassroots advocacy organization working to unite the SCI community and accelerate therapies that restore function after SCI.
A growing number of clinics are combining spinal stimulation with activity-based therapy to help restore function for people with spinal cord injuries.
Recently, I demolished my son’s wheelchair ramp and took it to the city dump. I didn’t tear it down because it's no longer needed. Eighteen years after he sustained a C5 spinal cord injury, my son still uses a wheelchair. Instead, wear and weather were turning the ramp back into the dirt from which it came, and it was no longer safe. Throwing the pieces into the scrap pile, I couldn’t help but reflect.   

Shortly after my son’s SCI, I committed myself to advancing research that could help him recover as much function as possible. It was work that I’d hoped would render his ramp obsolete or, at the very least, not essential. But here I am building a new one that is still quite essential. 

When the editors at New Mobility asked me to write a broad update about the state of SCI research, I thought about all the advances that have been made since I built that first ramp, but at the same time, how far we are from a world where ramps are obsolete. 

This newsletter will be about that exciting, ambiguous in-between. Before we get into the specifics, a few things to note:  First, I don’t want to add any more hyperbole to what advances are “just around the corner” or, dare I say, “in five years.” Second, I’m writing about things that provide meaningful promise for people who have been living with spinal cord injuries, not just the newly injured. Third, I’m not going to name any companies or scientists. Our community is often asked to "pick a winner." My loyalty is to restored function, not to who delivers it — because it always comes from a collective effort.
 

SPONSORED CONTENT
Be part of expanding real-world seating research. Take survey.
Help us better understand the realities of sitting
Our previous survey results helped guide solutions around the often overlooked experiences of sitting. No matter how long you sit, your input matters. Take a few minutes to contribute to ongoing seating and sitting research by completing the survey.

STIMULATION AND BCI SHOW REAL RESULTS
Things have changed since my son’s wheelchair ramp was first built. Back then, spinal stimulation — a strategy to electrically stimulate areas of the spinal cord either through the skin or surgically implanted on top of the cord — was producing some effect in individuals, but researchers didn’t yet understand how or why. Now it’s an accepted therapy you can pair with rehab both in the clinic and at home. 
A man with electrode pads taped to the back of his neck sits at a table working on a wooden pegboard, picking up small pegs with his hand while a researcher assists across from him.
Transcutaneous stimulation is allowing some quads to recover hand function.
And some folks are seeing functional recovery that was not previously possible. Skin surface stimulation — also known as transcutaneous stimulation — is letting some quads recover hand function like grasp and dexterity. Others who pursued implanted stimulators — also known as epidural stimulators — are seeing reduction in neuropathic pain, spasticity and in some cases improved sexual function. This is happening now, not five years from now.
 
Clinicians can program both surface stimulators and implanted stimulators to address the variability of each person’s injury and the desired functional outcome. This is what makes stimulation such an exciting, but complicated theory – it's not one setting fits all. We’re still in the early days, so the challenge will be defining the clinical protocols and the time required for gaining meaningful function. It’s also not yet clear who will benefit the most and what the ceiling for recovery will be.

Researchers and emerging companies are also using stimulation to target very specific functions like breathing, bowel, bladder and sexual function — either stimulating the cord at the levels responsible for these functions or implanting devices that stimulate the organs directly.
Brain computer interface allows a user to control a computer or other electronic devices using only their thoughts. Photo courtesy of Neuralink.
A cousin to spinal stimulation is brain computer interface. This field is also expanding quickly with a growing number of approaches to restore upper extremity function, sensation and, increasingly, efforts to pair it with spinal stimulation to route signals around the damage. 

DRUGS

Drug-based interventions are also showing positive effects in chronic injuries. They are moving to late-stage clinical trials and may soon gain regulatory approval as treatments. As with stimulation, the same questions remain. Who will benefit the most? How long will recovery take? And what is the ceiling for functional return? 
 
So far these types of treatments would fall into the category of pro-regenerative, not yet regenerative. Pro-regenerative refers to an intervention that creates a more permissive environment for regeneration. These approaches are trying to reduce the size of the scar or lesion after SCI, enhance connectivity in the spared tissue of the spinal cord or reduce inflammation in the spinal cord in the initial days and weeks after injury. When combined with another intervention such as rehabilitation or activity-based training/therapy, these approaches could lead to functional return for people living with SCI.
 
Regenerative refers to a therapy like stem cells or gene cocktails that regenerate lost or damaged tissue and inherently grow the connectivity required for functional recovery. Stem cells have received lots of attention but have yet to work well enough to break into treatment paradigms. Cell type, origin, purity, safety, survivability and functional connectivity have all been barriers to their success. These strategies continue to evolve, addressing those barriers with scaffolds, growth factors, genes and possible pairings with the innovations above.
 
Studies using psilocybin and other naturally occurring molecules are looking to harness the neuroplastic potential hidden behind hallucinatory experiences. The notion that changing your mind changes your body could open an array of treatments to compete with conventional drugs.
GET INVOLVED

All of the above raises a question that has grown more pervasive: How do we pair these strategies into smart combinations so people regain more function? Combinations complicate translation in standardized treatments — knowing what to combine and how — and regulators typically approve single therapies, not pairings. But since most scientists believe combinations will provide the most meaningful recovery for SCI, this is where we need the effort to go.
 
Which leads me to the most critical thing I have yet to mention: You. 
 
Our organization and many others are committed to influencing this whole research enterprise with our needs, goals and expectations. Many in the SCI community view research as a "spectator sport" or have no idea how to be anything but a spectator. The trouble is that research moves on with or without input from the people who have the most at stake. That’s on us, not anyone else. We must make our voices heard and hold public dollars, companies, regulators, healthcare and advocacy organizations accountable to what we want and need.
 
For years, much of the focus for SCI research was to get people walking again, even though many people with paralysis consider other priorities like bowel and bladder and sexual function to be more important.  Credit: EPFL Hillary Sanctuary
And we have to educate scientists as well. Scientists are experts in their fields, but who’s the expert at living with an SCI? That would be you. Too often researchers don’t fully consult the SCI community about risk/benefit, the outcomes that matter to us and who treatments will — and won't — work for. By the time a therapy comes to humans for testing, the path has already been set. So please do not read this, close the page, and consider your work done. You can: 
 
 
This has been a broad review, and I’m sure some of you recognize things I missed. If you have questions, criticism or suggestions, please reach out
 
U2FP is leading an effort with all of the national SCI organizations to develop a formal National Plan for SCI modeled after national plans for ALS, Alzheimer's and stroke. Enacted with congressional help, it would increase funding for research, quality of life efforts and access across the board. Stay tuned.
 
My son recently shared a hard epiphany that he will always be grieving what SCI has taken from him as he moves and matures through life, all the while embracing what that life has given him. That may be one broad definition of hope and what hope demands from any of us. We hold ourselves and the world as it is in the same hand with ourselves and the world we hope to see. That means examining the systems we inhabit and changing the ones that don't serve us. Our collective role is to bring that to the scientists, clinicians, companies, foundations and policy makers to move us all forward. We can’t do it unless we’re all in it together.



United Spinal logoNew Mobility publishes member content for United Spinal Association, whose mission is to improve quality of life of people with spinal cord injuries and all wheelchair users. It's free to join United Spinal. Join here.
 

No comments: